Vikas Lifecare [VIKASLIFE] vs Andrew Yule [ANDREWYU] Detailed Stock Comparison
Vikas Lifecare
NSE
Loading...
Andrew Yule
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Vikas Lifecare wins in 9 metrics, Andrew Yule wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Vikas Lifecare | Andrew Yule | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 62.00 | 97.44 | Vikas Lifecare |
| Price-to-Book Ratio | 0.60 | 4.76 | Vikas Lifecare |
| Debt-to-Equity Ratio | 14.39 | 31.10 | Vikas Lifecare |
| PEG Ratio | -0.44 | -1.04 | Andrew Yule |
| EV/EBITDA | -18.23 | -21.30 | Andrew Yule |
| Profit Margin (TTM) | -2.21% | -0.91% | Andrew Yule |
| Operating Margin (TTM) | -16.06% | -60.30% | Vikas Lifecare |
| Return on Equity | -2.16% | -0.84% | Andrew Yule |
| Return on Assets (TTM) | -2.76% | -7.31% | Vikas Lifecare |
| Free Cash Flow (TTM) | $-2.35B | $-235.61M | Andrew Yule |
| 1-Year Return | -56.13% | -51.60% | Andrew Yule |
| Price-to-Sales Ratio (TTM) | 0.86 | 4.18 | Vikas Lifecare |
| Enterprise Value | $3.94B | $16.81B | Andrew Yule |
| EV/Revenue Ratio | 0.82 | 5.39 | Vikas Lifecare |
| Gross Profit Margin (TTM) | 3.45% | 24.93% | Andrew Yule |
| Revenue per Share (TTM) | $2 | $7 | Andrew Yule |
| Earnings per Share (Diluted) | $-0.04 | $-0.06 | Vikas Lifecare |
| Beta (Stock Volatility) | -0.58 | 0.62 | Vikas Lifecare |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Vikas Lifecare vs Andrew Yule Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Vikas Lifecare | 0.45% | -6.72% | -13.28% | -6.72% | -39.01% | -48.01% |
| Andrew Yule | -0.37% | -7.65% | -14.41% | 1.14% | -27.78% | -32.03% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Vikas Lifecare | -56.13% | -55.15% | -82.30% | -52.77% | -52.77% | -52.77% |
| Andrew Yule | -51.60% | 25.51% | 65.96% | 6.68% | -36.35% | -20.98% |
Performance & Financial Health Analysis: Vikas Lifecare vs Andrew Yule
| Metric | VIKASLIFE | ANDREWYU |
|---|---|---|
| Market Information | ||
| Market Cap | ₹4.15B | ₹13.04B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 3,806,210 | 109,811 |
| 90 Day Avg. Volume | 4,124,557 | 91,474 |
| Last Close | ₹2.23 | ₹26.57 |
| 52 Week Range | ₹2.20 - ₹5.35 | ₹22.65 - ₹59.00 |
| % from 52W High | -58.32% | -54.97% |
| All-Time High | ₹18.56 (Aug 31, 2020) | ₹99.70 (Jan 18, 2010) |
| % from All-Time High | -87.98% | -73.35% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.03% | 0.29% |
| Quarterly Earnings Growth | 0.03% | 0.32% |
| Financial Health | ||
| Profit Margin (TTM) | -0.02% | -0.01% |
| Operating Margin (TTM) | -0.16% | -0.60% |
| Return on Equity (TTM) | -0.02% | -0.01% |
| Debt to Equity (MRQ) | 14.39 | 31.10 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹3.67 | ₹5.60 |
| Cash per Share (MRQ) | ₹0.04 | ₹0.64 |
| Operating Cash Flow (TTM) | ₹-2,222,031,872 | ₹-110,484,000 |
| Levered Free Cash Flow (TTM) | ₹104.68M | ₹2.22M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Vikas Lifecare vs Andrew Yule
| Metric | VIKASLIFE | ANDREWYU |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 62.00 | 97.44 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -0.44 | -1.04 |
| Price to Sales (TTM) | 0.86 | 4.18 |
| Price to Book (MRQ) | 0.60 | 4.76 |
| Market Capitalization | ||
| Market Capitalization | ₹4.15B | ₹13.04B |
| Enterprise Value | ₹3.94B | ₹16.81B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.82 | 5.39 |
| Enterprise to EBITDA | -18.23 | -21.30 |
| Risk & Other Metrics | ||
| Beta | -0.58 | 0.62 |
| Book Value per Share (MRQ) | ₹3.67 | ₹5.60 |
Financial Statements Comparison: Vikas Lifecare vs Andrew Yule
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | VIKASLIFE | ANDREWYU |
|---|---|---|
| Revenue/Sales | ₹1.35B | ₹975.11M |
| Cost of Goods Sold | ₹1.31B | ₹731.98M |
| Gross Profit | ₹46.64M | ₹243.12M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-217.09M | ₹-593.57M |
| EBITDA | ₹-16.61M | ₹-58.66M |
| Pre-Tax Income | ₹-52.39M | ₹-155.12M |
| Income Tax | ₹-24.17M | ₹-27.89M |
| Net Income (Profit) | ₹-28.22M | ₹-6.06M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | VIKASLIFE | ANDREWYU |
|---|---|---|
| Cash & Equivalents | ₹57.31M | ₹73.02M |
| Total Current Assets | ₹2.70B | ₹2.43B |
| Total Current Liabilities | ₹1.53B | ₹3.63B |
| Long-Term Debt | ₹388.22M | ₹15.32M |
| Total Shareholders Equity | ₹5.33B | ₹3.39B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹363.38M | ₹1.92B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | VIKASLIFE | ANDREWYU |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | VIKASLIFE | ANDREWYU |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 3,806,210 | 109,811 |
| Average Daily Volume (90 Day) | 4,124,557 | 91,474 |
| Shares Outstanding | 1.86B | 488.95M |
| Float Shares | 1.17B | 59.58M |
| % Held by Insiders | 0.20% | 0.91% |
| % Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Vikas Lifecare vs Andrew Yule
| Metric | VIKASLIFE | ANDREWYU |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | ₹0.00 |
| 3-Year Avg Dividend Yield | N/A | 0.03% |
| 3-Year Total Dividends | N/A | ₹0.01 |
| Ex-Dividend Date | N/A | Aug 24, 2023 |